文献速递其他结缔组织病

预测系统性硬化症相关间质性肺病肺功能下降轨迹

Predicting trajectories of lung function decline in systemic sclerosis-related interstitial lung disease.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

这项多中心回顾性研究纳入444例病程≤7年的系统性硬化症相关间质性肺病(SSc-ILD)患者,采用半参数潜类别分析识别出4组用力肺活量(FVC)下降轨迹。进展最快组FVC每年下降-2.18%,其死亡率高于稳定/缓慢进展组(HR 2.95,95%CI 1.74, 4.98),基线FVC≤72%预测进展轨迹的敏感度0.88、特异度0.91。

要点

  • 识别出4组FVC轨迹,进展最快组每年下降-2.18%,其余组稳定或缓慢进展。
  • 进展最快组死亡率高于稳定/缓慢进展组,HR 2.95(95%CI 1.74, 4.98)。
  • 基线FVC≤72%预测进展轨迹的敏感度0.88、特异度0.91。

核心结论

  • 不同的FVC轨迹与不同生存结局相关,进展性FVC轨迹最重要的预测因素是既有的ILD严重程度。
  • 需要更多工作评估影像学或辅助检查发现能否改善对 distinct FVC轨迹的预测。

研究设计与样本

  • 多中心回顾性研究,纳入444例系统性硬化症相关间质性肺病且病程≤7年的患者。
  • 采用半参数建模结合潜类别分析,按FVC下降轨迹对患者分组。
  • 比较最差FVC轨迹组与其他组的生存,并用向后选择的逻辑回归模型以基线疾病特征识别FVC轨迹预测因素。

主要发现

  • 识别出4组FVC轨迹,进展最快组每年下降-2.18%,其余三组稳定或进展缓慢。
  • 进展最快组死亡率高于稳定/缓慢FVC轨迹组,风险比(HR)2.95,95%CI 1.74, 4.98。
  • 基线FVC(P < 0.001)和C反应蛋白(CRP)升高(P = 0.039)与进展轨迹相关。
  • 基线FVC≤72%预测进展轨迹的敏感度0.88、特异度0.91。
  • 探索性分析中,较低的基线FVC与年龄较大、白种人、病程较长、抗拓扑异构酶I抗体阳性及CRP升高相关。

关键数值与推荐

  • 基线FVC≤72%预测进展性FVC轨迹,敏感度0.88、特异度0.91。
  • 进展最快组FVC每年下降-2.18%。
  • 进展最快组较稳定/缓慢FVC轨迹组死亡风险HR 2.95(95%CI 1.74, 4.98)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更多工作评估影像学或辅助检查发现能否改善对 distinct FVC轨迹的预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: SSc-related interstitial lung disease (SSc-ILD) is a major cause of morbidity. We aimed to identify patients following similar trajectories of forced vital capacity (FVC) decline, and examine their association with mortality and risk factors for FVC decline. METHODS: This is a multicentre retrospective study of 444 SSc patients with ILD and ≤7-year disease duration. Patients were grouped based on similar FVC decline trajectories using semi-parametric modelling with latent class analysis. Survival was compared between the worst FVC trajectory group and the others. Logistic regression models with backwards selection were applied to identify predictors of FVC trajectory using baseline disease features. RESULTS: Four FVC trajectory groups were identified. The most progressive trajectory declined by -2.18% per year and the other three trajectory groups were stable or progressed slowly. The most progressive group had a higher mortality rate than those with a stable/slow FVC trajectory (hazard ratio 2.95, 95% CI 1.74, 4.98). Baseline FVC (P < 0.001) and CRP elevation (P = 0.039) were associated the progressive trajectory. Baseline FVC ≤72% predicted the progressive trajectory with a sensitivity of 0.88 and specificity of 0.91. A lower baseline FVC was in turn associated with older age, Caucasian race, longer disease duration, anti-topoisomerase I presence and elevated CRP on exploratory analyses. CONCLUSION: Distinct FVC trajectories are associated with different survival outcomes and the most important predictor of a progressive FVC trajectory was existing ILD severity. More work is needed to assess the utility of imaging or paraclinical findings that can improve prediction of distinct FVC trajectories.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zheng B, Nikpour M, Stevens W, et al. Predicting trajectories of lung function decline in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). 2025. PMID: 40457812. doi:10.1093/rheumatology/keaf270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。